COLCOM

COLCOM is a French biotechnology company specializing in the development and production of Dendrigrafts of Lysine (DGL), a unique class of monodispersed, biodegradable, and non-immunogenic poly-L-lysine dendrimers. Based in Montarnaud, the company offers a versatile nanotechnology platform used for targeted drug delivery, gene therapy, and regenerative medicine applications. COLCOM operates primarily as a high-tech supplier and contract research organization (CRO), providing customized biopolymer solutions and functionalization services to adapt DGL for specific therapeutic payloads such as small molecules, peptides, and nucleic acids. Its proprietary DGL technology is distinguished by its precise molecular architecture and high reproducibility, making it an attractive platform for advanced research in oncology and infectious diseases.